Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Smit, Wim M"'
Autor:
Steenbruggen, Tessa G, Steggink, Lars C, Seynaeve, Caroline M, van der Hoeven, Jacobus J M, Hooning, Maartje J, Jager, Agnes, Konings, Inge R, Kroep, Judith R, Smit, Wim M, Tjan-Heijnen, Vivianne C G, van der Wall, Elsken, Bins, Adriaan D, Linn, Sabine C, Schaapveld, Michael, Jacobse, Judy N, van Leeuwen, Flora E, Schröder, Carolien P, van Tinteren, Harm, de Vries, Elisabeth G E, Sonke, Gabe S, Gietema, Jourik A
Publikováno v:
JAMA oncology, 6(4), 528-534. AMER MEDICAL ASSOC
Importance: Trials of adjuvant high-dose chemotherapy (HDCT) have failed to show a survival benefit in unselected patients with breast cancer, but long-term follow-up is lacking. Objective: To determine 20-year efficacy and safety outcomes of a large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::7d7f0a1f741cd70d16d3cc0637abdf5f
https://research.rug.nl/en/publications/93497ccd-c88b-47b2-99f1-11b64ce0d0c1
https://research.rug.nl/en/publications/93497ccd-c88b-47b2-99f1-11b64ce0d0c1
Autor:
Posthuma, Eduardus F.M *, Marijt, Erik W.A.F, Barge, Renee M.Y, van Soest, Ronald A, Baas, Inge O, Starrenburg, C.W.J.Ingrid, van Zelderen-Bhola, Shama L, Fibbe, Willem E, Smit, Wim M, Willemze, Roel, Falkenburg, J.H.Frederik
Publikováno v:
In Biology of Blood and Marrow Transplantation 2004 10(3):204-212
Publikováno v:
Gynecological Endocrinology. May2005, Vol. 20 Issue 5, p274-278. 5p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cornelissen, Jan J., Valk, Peter, Verhoef, Gregor E.G., Smit, Wim M. *, van Marwijk-Kooij, Marinus *, Wittebol, Shulamit *, van Oers, Marinus H.J., Kluin-Nelemans, Hanneke C., Lowenberg, Bob, Willemze, Roelof, Schattenberg, Antonius V.M.B., Ossenkoppele, Gert
Publikováno v:
In Blood 16 November 2004 104(11):19-19
Autor:
Steenbruggen TG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Steggink LC; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Seynaeve CM; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., van der Hoeven JJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Konings IR; Department of Medical Oncology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Smit WM; Department of Internal Medicine/Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., van der Wall E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Bins AD; Department of Medical Oncology, Amsterdam UMC, location AMC, Amsterdam, the Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Schaapveld M; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Jacobse JN; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., van Leeuwen FE; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., van Tinteren H; Department of Biostatistics, the Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2020 Apr 01; Vol. 6 (4), pp. 528-534.
Autor:
Helgason HH, Koolen SL, Werkhoven Ev, Malingre MM, Kruijtzer CM, Huitema AD, Schot ME, Smit WM, Beijnen JH, Schellens JH; Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.schellens@nki.nl.
Publikováno v:
Current clinical pharmacology [Curr Clin Pharmacol] 2014 May; Vol. 9 (2), pp. 139-47.